Breast Cancer Due to Non– BRCA1 and Non– BRCA2 Mutations in Ashkenazi Jewish Women

This cohort study uses genomic DNA from the New York Breast Cancer Study to determine the frequency of cancer-predisposing mutations other than the BRCA1 and BRCA2 founder alleles among patients of Ashkenazi Jewish ancestry with breast cancer.

http://ift.tt/2uGlokZ